16 Nov 2022

End to End Sterility Assurance for Next Level Risk Mitigation

In this webinar, originally broadcast as part of the Pharmapack Europe show, Dr. Robert Lindner, Global Product Manager RTU Vials, SCHOTT AG will discuss how sterile integrity is indispensable in aseptic fill-and-finish operations. Pharmaceutical companies pay highest attention to producing high quality drugs and safekeeping their efficacy during fill-and-Finish and beyond. The risks of contaminated batches leads to recalls, high costs, reputation loss and in the worst scenario may harm patients’ wellbeing. Hence, it is the pharma company’s obligation to ensure the sterility of all components when entering the aseptic filling core - which is possible, yet cumbersome with the RTU solutions that are currently available within the industry.

Content provided by our supplier

SCHOTT Pharma AG & Co. KGaA

  • DE
  • 2015
    On CPHI since

Other Content from SCHOTT Pharma AG & Co. KGaA (2)